Diane
Diane is a pianist, a mother, and a frequent traveler. She was diagnosed with MS in 2001. Her doctor recommended switching to TASCENSO ODT to avoid the potential inconsistencies of generic fingolimod capsules.
Gina
Gina loves life and having a good time. She was diagnosed with MS in 1994. She’s recently switched from Gilenya® (fingolimod) capsules to TASCENSO ODT, an orally disintegrating tablet.
Taia
Taia is from Texas and was diagnosed with MS in 2023 when she was 24 years old. TASCENSO ODT is her first disease modifying treatment for MS and she describes the experience as a breeze.
Share your story
If you are a patient taking TASCENSO ODT, we’d love to hear your story and add it to this page! If you would like to share your story, please contact your Clinical Education Manager at Cycle Vita™.
+1 (888) 360-8482
Gilenya® is a registered trademark of Novartis AG.